1 Min Read
July 19 (Reuters) - Promis Neurosciences Inc
* Initiated a program to identify novel therapeutic targets on neurotoxic strains of protein TDP43 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.